StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

NCT02765997 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IRB Disapproval

Conditions

Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Myelodysplasia

Interventions

BIOLOGICAL: Unmanipulated UCB
BIOLOGICAL: SR-1 UCB

Sponsor

Masonic Cancer Center, University of Minnesota